Venetoclax-based regimens showed a trend toward improved survival compared to BTK inhibitors, although subgroup sizes were small.

Adding an immune checkpoint inhibitor to neoadjuvant chemotherapy can improve pathologic complete response rates and may improve survival in patients with muscle-invasive bladder cancer, research ...

Tumor volume and CP score were top predictors of OS, along with liver gross tumor volume, functional liver volume V20, and prior liver-directed therapy.

It is important for health care providers “to understand how to protect their patients, including their physical and legal security as well as the privacy of their data,” said Leighton Ku, PhD.

HealthDay News — Race definitions have limited impact on cancer rates for Whites, Blacks, and Asians, but do impact rates in multiracial individuals, according to a study published online July 21 in ...

A review of the literature revealed that immune effector cell-associated neurotoxicity syndrome (ICANS) is a common adverse effect of CAR-T therapy.

Relacorilant plus nab-paclitaxel could be a new standard of care for platinum-resistant ovarian cancer, according to Alexander Olawaiye, MD.

After transformation, survival rates varied by original cancer type, with the poorest prognosis for those transformed from CLL/SLL and from LPL/WM.

In patients with multiple myeloma (MM), serum concentration of chitinase 3-like protein-1 (CHI3L1) protein is correlated with disease severity and predicts disease progression, according to research ...

Launch prices for self-administered targeted anticancer therapies have grown precipitously,” researchers wrote.

AJCC9V staging system showed superior hazard consistency, outcome prediction, and balance, but not hazard discrimination.

We were able to detect 100% of recurrences by ctDNA ahead of clinical recurrence, which included all lung metastases as well as other distant metastases,” said Emma Titmuss.